These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3267160)

  • 1. Thymic T-cell lymphoma with the CD8+ (OX-8), CD4+ (W3/25) phenotype, induced in F344/NCr rats by nitroso-2-hydroxypropylurea.
    Konishi N; Ward JM; Reynolds CW; Lijinsky W
    Thymus; 1988-1989; 12(4):225-37. PubMed ID: 3267160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of thymic lymphomas by oral administration of N-nitroso-N-propylurea and establishment of transplantable lines of thymic lymphoma in F344 rats.
    Sakura Y; Ogiu T; Imamura N; Furuta K; Matsuoka C; Odashima S
    J Natl Cancer Inst; 1984 Sep; 73(3):757-62. PubMed ID: 6088882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent induction of thymic lymphomas by N-propyl-N-nitrosourea in the F344/DuCrj rat.
    Ogiu T; Fukami H; Nishimura M; Shimada Y; Maekawa A
    Thymus; 1992 Dec; 20(4):249-58. PubMed ID: 1492363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existence of N-nitroso-N-propylurea target cells in the thymus of F344 rats in thymic lymphomagenesis.
    Ogiu T; Fukami H
    J Natl Cancer Inst; 1987 Jul; 79(1):179-83. PubMed ID: 3298785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic characteristics of thymic lymphomas induced by N-nitroso-N-propylurea in F344 rats.
    Suzuki Y; Matsuyama M; Ogiu T
    J Natl Cancer Inst; 1984 Feb; 72(2):367-73. PubMed ID: 6582322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the thymus in propylnitrosourea-induced thymic lymphomagenesis in F344 rats.
    Shisa H; Kitano M
    Jpn J Cancer Res; 1986 Jun; 77(6):572-8. PubMed ID: 3089991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenicity of 2',3'-dideoxycytidine in mice.
    Rao GN; Collins BJ; Giles HD; Heath JE; Foley JF; May RD; Buckley LA
    Cancer Res; 1996 Oct; 56(20):4666-72. PubMed ID: 8840982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of mononuclear cells infiltrating into tumors. III. Soluble factors involved in the regulation of T lymphocyte infiltration into tumors.
    Yamaki T; Uede T; Shijubo N; Kikuchi K
    J Immunol; 1988 Jun; 140(12):4388-96. PubMed ID: 3286773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically determined susceptibility of Fischer 344 rats to propylnitrosourea-induced thymic lymphomas.
    Shisa H; Hiai H
    Cancer Res; 1985 Apr; 45(4):1483-7. PubMed ID: 3978615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
    Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
    Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of T-cell receptor beta chain gene rearrangements and ras oncogene mutations in the development of murine thymic lymphomas.
    Sloan SR; Pellicer A
    Cancer Res; 1991 Mar; 51(6):1627-31. PubMed ID: 1847841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of prelymphoma cells committed to thymic lymphomas during radiation-induced thymic lymphomagenesis in B10 mice.
    Muto M; Kubo E; Sado T
    Cancer Res; 1987 Jul; 47(13):3469-72. PubMed ID: 3495331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deviated overexpression of TCR-beta, TCR-gamma, CD4, and CD8 on thymic lymphomas induced by 1-propyl-1-nitrosourea: destruction of the allelic exclusion of TCR-beta and expression of functional TCR-betagamma heterodimer on a lymphoma, cFTL53.
    Kinebuchi M; Matsuura A; Ogiu T; Kikuchi K
    J Immunol; 1997 Jul; 159(2):748-56. PubMed ID: 9218591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
    Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
    J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential observations of thymic lymphoma development induced in 10-week-old F344 rats by N-propyl-N-nitrosourea.
    Ogiu T; Sakura Y; Maekawa A
    Acta Pathol Jpn; 1985 Sep; 35(5):1191-200. PubMed ID: 4083001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action site of the gene determining susceptibility to propylnitrosourea-induced thymic lymphomas in F344 rats.
    Shisa H; Suzuki M
    Jpn J Cancer Res; 1991 Jan; 82(1):46-50. PubMed ID: 1900267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD95 ligand mediates T-cell receptor-induced apoptosis of a CD4+ CD8+ double positive thymic lymphoma.
    Schmitz I; Meyer C; Schulze-Osthoff K
    Oncogene; 2006 Dec; 25(58):7587-96. PubMed ID: 16767155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-3 increases the incidence of 5-azacytidine-induced thymic lymphomas in pBOR-Il-3 mice.
    Saavedra HI; Wang TH; Hoyt PR; Popp D; Yang WK; Stambrook PJ
    Cell Immunol; 1996 Oct; 173(1):116-23. PubMed ID: 8871607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.